99 related articles for article (PubMed ID: 1098749)
1. [Recent progress in the hormonal treatment of sterility].
Fanard A
Brux Med; 1975 Jul; 55(7):401-14. PubMed ID: 1098749
[TBL] [Abstract][Full Text] [Related]
2. Recombinant gonadotropins.
Lathi RB; Milki AA
Curr Womens Health Rep; 2001 Oct; 1(2):157-63. PubMed ID: 12112963
[TBL] [Abstract][Full Text] [Related]
3. Ovulation induction: ovarian response to human gonadotropins and synthetic gonadotropin-releasing hormone.
Zanartu J; Dabancens A; Rodriguez-Bravo R; Barsby F; Schally AV
Obstet Gynecol; 1975 Apr; 45(4):443-50. PubMed ID: 47625
[TBL] [Abstract][Full Text] [Related]
4. [Induction of ovulation: Comparative study on the response of the ovary to the treatment with human gonadotropins, synthetic hypothalamic gonadotropin-releasing hormone (LH-RH) and nonhormonal agents (clomiphene, cyclophenyl, etc). Therapeutic studies on the treatment of anovulatory sterility].
Zañartu J; Dabancens A; Rodríguez-Bravo R; Schally AV
Rev Chil Obstet Ginecol; 1973; 38(5):240-51. PubMed ID: 4619840
[No Abstract] [Full Text] [Related]
5. [Application of ultra-short gonadotropin-releasing hormone agonist protocol in controlled ovarian hyperstimulation].
Zhao X; Zhang L; Gong S
Zhonghua Fu Chan Ke Za Zhi; 1997 Oct; 32(10):589-92. PubMed ID: 9642373
[TBL] [Abstract][Full Text] [Related]
6. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
[TBL] [Abstract][Full Text] [Related]
7. [The plasma and urinary hormone profiles during treatment with human gonadotrophins (author's transl)].
Salat-Baroux J; Scemama-Kestenberg H
J Gynecol Obstet Biol Reprod (Paris); 1978; 7(7):1269-90. PubMed ID: 744868
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
Krause BT; Ohlinger R
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of gonadotropins and LH-releasing hormone in the clinical practice].
Groot Wassink K
Z Arztl Fortbild (Jena); 1975 Oct; 69(20):1067-9. PubMed ID: 1108466
[No Abstract] [Full Text] [Related]
10. Ovulatory disorders in women with polycystic ovary syndrome.
Franks S; Adams J; Mason H; Polson D
Clin Obstet Gynaecol; 1985 Sep; 12(3):605-32. PubMed ID: 3933879
[TBL] [Abstract][Full Text] [Related]
11. Comparison of recombinant human luteinising hormone (r-hLH) and human menopausal gonadotropin (hMG) in assisted reproductive technology.
Baer G; Loumaye E
Curr Med Res Opin; 2003; 19(2):83-8. PubMed ID: 12740151
[TBL] [Abstract][Full Text] [Related]
12. Management of anovulation.
Adams M; Cooke ID
Clin Obstet Gynaecol; 1974 Aug; 1(2):285-311. PubMed ID: 4620625
[No Abstract] [Full Text] [Related]
13. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
Venturoli S; Paradisi R; Fabbri R; Porcu E; Orsini LF; Flamigni C
Int J Fertil; 1987; 32(1):66-70. PubMed ID: 2880819
[TBL] [Abstract][Full Text] [Related]
14. A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization.
Costello MF; Hughes GJ; Garrett DK; Hanjani A; Steigrad SJ
Int J Fertil Womens Med; 1998; 43(1):28-33. PubMed ID: 9532467
[TBL] [Abstract][Full Text] [Related]
15. [Clinical results with hypothalamic gonadotropin releasing hormone (LH-RH) and the treatment of anovulatory sterility].
Figueroa Casas PR; Badano AR; Aparicio NJ; Miechi H; Mirkin A; Bicocca C
Obstet Ginecol Lat Am; 1974; 32(7-8):257-63. PubMed ID: 4618533
[No Abstract] [Full Text] [Related]
16. [Measurement of plasma FSH and LH in sterile women treated with human gonadotropins].
Bolte E; Jaffe RB
Union Med Can; 1974 Apr; 103(4):653-6. PubMed ID: 4839686
[No Abstract] [Full Text] [Related]
17. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
Nillius SJ; Bergquist C; Wide L
Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
[TBL] [Abstract][Full Text] [Related]
18. [Contribution of human menopausal gonadotropins purified as to their FSH content in anovulatory sterility presenting a difficult treatment problem].
Emperaire JC; Ruffié A; Audebert AJ
J Gynecol Obstet Biol Reprod (Paris); 1987; 16(5):621-6. PubMed ID: 3117873
[TBL] [Abstract][Full Text] [Related]
19. [The treatment of sterility with human gonadotropins. (HMG-HCG)].
Montanino G; Coghi I; Carenza L
Patol Clin Ostet Ginecol; 1973; 1(3):108-17. PubMed ID: 4806755
[No Abstract] [Full Text] [Related]
20. [A hormone assay as a therapeutic choice in male sterility].
Avril-Ducarne C; Kuhn JM; Cossec A; Bastit P; Bisson JP; Wolf LM
J Gynecol Obstet Biol Reprod (Paris); 1990; 19(7):881-8. PubMed ID: 2126018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
